6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50

Description

6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50

6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50 is a bulk listing for a product identified as tamoxifen 20mg, commonly associated with the brand name Nolvadex. The supplied listing contains 6 packs of 50 tablets, providing 300 tablets in total, with a stated strength of 20mg per tablet.

Tamoxifen is a selective oestrogen receptor modulator (SERM) and is an established prescription medicine. Current UK-authorised tamoxifen products are indicated for conditions including breast cancer, anovulatory infertility and, for appropriate women at moderate or high risk, primary prevention of breast cancer.

The specific Pharmaqo Tamoxifen/Nolvadex 20mg x 50 product should not automatically be assumed to be identical to an authorised UK Nolvadex or tamoxifen product. Its manufacturer, formulation, excipients, regulatory status and authenticity should be independently verified.

Classification

Product type: Selective oestrogen receptor modulator (SERM)
Active ingredient: Tamoxifen
Listed strength: 20mg per tablet
Pack size: 50 tablets
Bulk quantity: 6 x 50 = 300 tablets
UK medicine category: Tamoxifen is available as a prescription-only medicine (POM)

Current UK-authorised tamoxifen 20mg tablets contain 20mg tamoxifen as tamoxifen citrate and are supplied under marketing authorisations held by UK pharmaceutical companies.

What is 6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50?

6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50 is a bulk presentation of tablets labelled as tamoxifen 20mg.

Tamoxifen belongs to a group of medicines called anti-oestrogens. It has a complex tissue-specific effect on oestrogen receptors and is particularly important in the management of hormone-sensitive breast cancer.

The name Nolvadex is associated with tamoxifen, but a product using the name “Nolvadex” should not automatically be assumed to be the original AstraZeneca medicine. The specific Pharmaqo product should be checked against its packaging and regulatory documentation.

Dosage

Dosage depends on the medical indication and should follow the prescribing information for an authorised tamoxifen medicine.

For breast cancer, current UK product information states that the recommended adult dose is normally 20mg daily. For primary prevention of breast cancer in appropriately selected women at moderate or high risk, the recommended dose is 20mg daily for five years, with treatment initiated within an appropriate specialist/shared-care pathway.

Tamoxifen is also used for anovulatory infertility, where the dosing regimen differs and requires medical supervision.

These licensed regimens should not be repurposed as a self-directed post-cycle therapy (PCT), bodybuilding protocol or treatment for anabolic-steroid side effects.

How Does Pharmaqo Tamoxifen/Nolvadex 20mg x 50 Work?

Tamoxifen is a selective oestrogen receptor modulator.

It competes with oestrogen for binding to oestrogen receptors in target tissues. Its effect is tissue-dependent: it primarily acts as an anti-oestrogen in breast tissue while displaying oestrogen-like activity in some other tissues.

Tamoxifen is metabolised in the body to active metabolites, including endoxifen, which contributes significantly to its pharmacological activity.

Potential Benefits

When prescribed for an approved indication, tamoxifen can provide clinically important benefits.

Potential therapeutic benefits include:

• Treatment of hormone-sensitive breast cancer
• Reduction in the risk of breast cancer recurrence in appropriate patients
• Reduction of breast cancer risk in selected women at moderate or high risk
• Treatment of certain forms of anovulatory infertility

The specific benefit depends on the patient’s condition, tumour characteristics, menopausal status and treatment plan.

Tamoxifen should not be presented as an established treatment for increasing testosterone, preventing all anabolic-steroid side effects or improving bodybuilding performance.

When Should You Not Take Pharmaqo Tamoxifen/Nolvadex 20mg x 50?

Tamoxifen should not be used in people with a known hypersensitivity to tamoxifen or its ingredients. It is contraindicated during pregnancy. Current product information also specifies additional contraindications depending on the indication, including certain thromboembolic-risk situations when tamoxifen is used for infertility.

Tamoxifen should not be taken together with anastrozole for the licensed indications unless specifically directed by an appropriate specialist, as the current UK SmPC lists concurrent anastrozole therapy as contraindicated.

Medical advice is particularly important for people with a history of blood clots, unexplained vaginal bleeding, liver disease, visual problems or other significant medical conditions.

Mechanism

Tamoxifen binds to oestrogen receptors and modifies oestrogen signalling.

In breast tissue, this predominantly produces an anti-oestrogen effect, reducing oestrogen-mediated stimulation of susceptible breast-cancer cells. In other tissues, tamoxifen can demonstrate partial oestrogen-like activity.

This selective receptor activity explains why tamoxifen can have different effects in breast, bone, endometrial and other tissues.

Uses

Current UK-authorised tamoxifen products have three principal recognised uses:

1. Treatment of breast cancer
2. Treatment of anovulatory infertility
3. Primary prevention of breast cancer in appropriately selected women at moderate or high risk

Although tamoxifen is frequently discussed online in connection with anabolic-steroid use, its authorised UK indications do not include bodybuilding, muscle growth or routine post-cycle therapy.

Warnings and Precautions

Tamoxifen requires appropriate medical supervision because it can produce clinically significant adverse effects.

Important considerations include:

• Increased risk of venous thromboembolism
• Changes to the endometrium
• Abnormal vaginal bleeding requiring investigation
• Visual disturbances and cataracts
• Liver-function abnormalities
• Potential interactions with medicines affecting CYP2D6
• Menstrual changes
• Effects on fertility and reproductive function
• Possible QT-interval effects in susceptible patients

Long-term tamoxifen treatment requires appropriate monitoring according to the indication. Patients should report unexplained vaginal bleeding, changes in vision, leg swelling, chest pain or sudden shortness of breath promptly.

Side Effects

Possible adverse effects of tamoxifen include:

• Hot flushes
• Nausea
• Fatigue
• Headache
• Dizziness
• Vaginal discharge or bleeding
• Menstrual changes
• Skin reactions
• Fluid retention
• Visual disturbances
• Cataracts
• Changes in liver-function tests
• Thromboembolic events

More serious reactions include deep-vein thrombosis and pulmonary embolism. Tamoxifen has also been associated with changes to the endometrium, including an increased risk of endometrial cancer with long-term exposure.

Seek urgent medical attention for symptoms suggestive of a blood clot, such as sudden chest pain, unexplained breathlessness or painful swelling of a leg.

Storage

Storage requirements depend on the exact formulation.

For example, a current UK-authorised tamoxifen 20mg tablet product specifies storage below 25°C in the original package, protected from light and moisture.

For 6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50, follow the storage instructions supplied with the original product. Keep tablets securely away from children and do not use products beyond their stated expiry date.

Where to Buy 6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50?

To get 6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50 online, go to Steroid Sanctuary today to get the best deal on this medicine.

Frequently Asked Questions

1. What is 6 x Pharmaqo Tamoxifen/Nolvadex 20mg x 50?

It is a bulk listing containing 6 packs of 50 tablets, giving 300 tablets in total, with a stated strength of 20mg tamoxifen per tablet.

2. Is Nolvadex the same as tamoxifen?

Nolvadex is a recognised brand name associated with tamoxifen. However, different manufacturers may produce authorised generic tamoxifen medicines, and a product labelled “Nolvadex” should not automatically be assumed to be the original branded medicine.

3. What is tamoxifen officially used for?

UK-authorised tamoxifen products are used to treat breast cancer, treat anovulatory infertility and, in appropriate women at moderate or high risk, reduce the risk of developing breast cancer.

4. Is 20mg a standard tamoxifen dose?

For breast cancer, the current UK product information states that the normal recommended adult dose is 20mg daily. Other indications can have different treatment requirements, so dosing should follow the applicable prescribing information.

5. Can tamoxifen cause blood clots?

Yes. Venous thromboembolism, including deep-vein thrombosis and pulmonary embolism, is a recognised risk associated with tamoxifen. People experiencing symptoms such as sudden breathlessness, chest pain or significant leg swelling should seek urgent medical attention.